HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Features of the superficial white matter as biomarkers for the detection of Alzheimer's disease and mild cognitive impairment: A diffusion tensor imaging study.

AbstractBACKGROUND:
With the development of medical imaging and processing tools, accurate diagnosis of diseases has been made possible by intelligent systems. Owing to the remarkable ability of support vector machines (SVMs) for diseases diagnosis, extensive research has been conducted using the SVM algorithm for the classification of Alzheimer's disease (AD) and mild cognitive impairment (MCI).
OBJECTIVES:
In this study, we applied an automated method to classify patients with AD and MCI and healthy control (HC) subjects based on the diffusion tensor imaging (DTI) features in the superficial white matter (SWM).
PARTICIPANTS:
For this purpose, DTI data were downloaded from the Alzheimer's Disease Neuroimaging Initiative (ADNI). This method employed DTI data from 72 subjects: 24 subjects as HC, 24 subjects with MCI, and 24 subjects with AD.
MEASURE:
ments: DTI processing was performed using DSI Studio software and all machine learning analyses were performed using MATLAB software.
RESULTS:
The linear kernel of SVM was the best classifier, with an accuracy of 95.8% between the AD and HC groups, followed by the quadratic kernel of SVM with an accuracy of 83.3% between the MCI and HC groups and the Gaussian kernel of SVM with an accuracy of 83.3% between the AD and MCI groups.
CONCLUSIONS:
Given the importance of diagnosing AD and MCI as well as the role of superficial white matter in the diagnosis of neurodegenerative diseases, in this study, the features of different DTI methods of the SWM are discussed, which could be a useful tool to assist in the diagnosis of AD and MCI.
AuthorsBahare Bigham, Seyed Amir Zamanpour, Hoda Zare, Alzheimer's Disease Neuroimaging Initiative
JournalHeliyon (Heliyon) Vol. 8 Issue 1 Pg. e08725 (Jan 2022) ISSN: 2405-8440 [Print] England
PMID35071808 (Publication Type: Journal Article)
Copyright© 2022 The Authors. Published by Elsevier Ltd.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: